Flavia Marturana

Computer-Aided Design, Synthesis, and Anti-HIV-1 Activity in Vitro of 2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3<i>H</i>)- ones as Novel Potent Non-Nucleoside Reverse Transcriptase Inhibitors, Also Active Against the Y181C Variant

Rino Ragno, Antonello Mai, Gianluca Sbardella et al. · Journal of Medicinal Chemistry · 2004 · 76 citations · Full text

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines

Majid Momeny, Jodi M. Saunus, Flavia Marturana et al. · Oncotarget · 2015 · 71 citations · Full text

Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells

Nicholas Timmins, Emma Palfreyman, Flavia Marturana et al. · Biotechnology and Bioengineering · 2009 · 55 citations

5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family

Antonello Mai, Marino Artico, Rino Ragno et al. · Bioorganic & Medicinal Chemistry · 2005 · 43 citations

Medicinal Chemistry, Drug Target, Dabo Family +10

Short-term exposure of umbilical cord blood CD34+ cells to granulocyte–macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils

Flavia Marturana, Nicholas Timmins, Lars K. Nielsen · Cytotherapy · 2010 · 15 citations

Inflammation, Ex Vivo Expansion, Short-term Exposure +12